NCT06393478 Southeastern Europe Microcirculation Registry
| NCT ID | NCT06393478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute for Cardiovascular Diseases Dedinje |
| Condition | Angina, Microvascular |
| Study Type | OBSERVATIONAL |
| Enrollment | 900 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2029-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 900 participants in total. It began in 2024-03-01 with a primary completion date of 2029-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
SATURATION is a prospective multicenter registry of consecutive patients who undergo coronary physiology testing using Pressure Wire X and Coroflow Coroventis Cardiovascular System software (Abbott Vascular, Abbott Park, IL, USA) and to assess the regional practice of patient selection, cardiovascular outcomes and additional procedures (stress testing, angiography, etc.) done after comprehensive invasive coronary physiology evaluation.
Eligibility Criteria
Inclusion Criteria: * Adults of both sexes older than 18 years * Angina symptoms or angina equivalent * Referred to Cath lab for evaluation of CAD * Invasive physiology testing performed (microcirculation testing +/- vasospasm testing) using Coroflow Coroventis Cardiovascular system (Abbott Vascular, Abbott Park, IL, USA) Exclusion Criteria: * Persons under the age of 18 * Pregnant of nursing * No coronary physiology measurements performed
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06393478 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Angina, Microvascular. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06393478 currently recruiting?
Yes, NCT06393478 is actively recruiting participants. Contact the research team at ivan1ilic@yahoo.com for enrollment information.
Where is the NCT06393478 trial being conducted?
This trial is being conducted at Rijeka, Croatia, Zagreb, Croatia, Athens, Greece, Athens, Greece and 6 additional locations.
Who is sponsoring the NCT06393478 clinical trial?
NCT06393478 is sponsored by Institute for Cardiovascular Diseases Dedinje. The trial plans to enroll 900 participants.